Pérez‐Fontan 1992.
Methods | Randomised, prospective trial. | |
Participants | CAPD patients. All carriers. Mupirocin: 11. Neomycin: 8. No significant difference between both groups. | |
Interventions | Mupirocin or Neomycin. Mupirocin thrice daily for 7 days. Neomycin sulphate thrice daily for 7 days. | |
Outcomes | S. aureus infection rate. Adverse events. Infection rate caused by other micro‐organisms than S. aureus. | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | Unclear |